- Home
- ACLS vs LIVN Comparison
ACLS vs LIVN Comparison
Compare ACLS & LIVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACLS
- LIVN
- Stock Information
- Founded
- ACLS 1995
- LIVN 1987
- Country
- ACLS United States
- LIVN United Kingdom
- Employees
- ACLS N/A
- LIVN N/A
- Industry
- ACLS Industrial Machinery/Components
- LIVN Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- ACLS Technology
- LIVN Health Care
- Exchange
- ACLS Nasdaq
- LIVN Nasdaq
- Market Cap
- ACLS 1.8B
- LIVN 2.2B
- IPO Year
- ACLS 2000
- LIVN 1993
- Fundamental
- Price
- ACLS $50.96
- LIVN $39.50
- Analyst Decision
- ACLS Buy
- LIVN Buy
- Analyst Count
- ACLS 7
- LIVN 7
- Target Price
- ACLS $156.00
- LIVN $60.29
- AVG Volume (30 Days)
- ACLS 633.1K
- LIVN 726.9K
- Earning Date
- ACLS 04-30-2025
- LIVN 05-07-2025
- Dividend Yield
- ACLS N/A
- LIVN N/A
- EPS Growth
- ACLS N/A
- LIVN 262.50
- EPS
- ACLS 6.15
- LIVN 1.16
- Revenue
- ACLS $1,017,865,000.00
- LIVN $1,253,437,000.00
- Revenue This Year
- ACLS N/A
- LIVN $5.79
- Revenue Next Year
- ACLS $11.97
- LIVN $5.35
- P/E Ratio
- ACLS $8.29
- LIVN $34.14
- Revenue Growth
- ACLS N/A
- LIVN 8.66
- 52 Week Low
- ACLS $47.23
- LIVN $36.85
- 52 Week High
- ACLS $158.61
- LIVN $64.48
- Technical
- Relative Strength Index (RSI)
- ACLS 32.57
- LIVN 41.72
- Support Level
- ACLS $47.23
- LIVN $38.53
- Resistance Level
- ACLS $58.41
- LIVN $40.30
- Average True Range (ATR)
- ACLS 1.99
- LIVN 1.02
- MACD
- ACLS -0.47
- LIVN 0.22
- Stochastic Oscillator
- ACLS 28.96
- LIVN 31.74
About ACLS Axcelis Technologies Inc.
Axcelis Technologies Inc designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips. In addition to equipment, the company provides aftermarket lifecycle products and services, including used tools, spare parts, equipment upgrades, maintenance services, and customer training. Geographically, the group has a business presence in North America, Asia Pacific, and Europe, of which key revenue is derived from the Asia Pacific.
About LIVN LivaNova PLC
UK-based Livanova was born of a combination between Cyberonics in the US and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, Livanova divested its cardiac rhythm management, heart valve, and extracorporeal membrane oxygenation businesses. It derives roughly half of its revenue from the US market, another 21% from Europe, and the remainder from the rest of the world.